Literature DB >> 11849625

Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children.

A B Erbağci1, M Tarakçioğlu, Y Coşkun, E Sivasli, E Sibel Namiduru.   

Abstract

OBJECTIVES: Recent evidence favors primary role of cellular autoimmunity and its humoral mediators in pathogenesis and following Type I diabetes mellitus (DM). The present study was carried out to investigate serum concentrations of C-reactive protein (CRP), interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF)-alpha in children with type I DM. Potential role of lipid metabolism, glycemic control, body mass index (BMI) and disease duration were evaluated. DESIGN AND METHODS: Thirty-five children with type I DM and 30 age and gender matched nondiabetic controls were recruited for this study.
RESULTS: Circulating IL-8 levels were elevated in children with type I DM (12.7 +/- 1.7 pg/mL) compared with nondiabetic controls (5.5 +/- 0.3 pg/mL) and the difference remained significant after adjustment for cofactors and covariates (p: 0.033). Although statistically insignificant serum CRP concentrations were slightly higher in diabetic children (p: 0.075). Serum TNF-alpha and IL-6 levels were comparable in diabetic and nondiabetic groups. However newly diagnosed (<1 yr) cases had higher TNF-alpha and IL-6 levels compared to cases with longer standing DM. In diabetic children BMI was independently associated with an increase in serum IL-8 levels. Serum CRP, lipids, apolipoproteins and glycemic control were not significant predictors of cytokine concentrations in children with type I DM.
CONCLUSION: Circulating levels of IL-8 were elevated and were correlated with BMI in children with type I DM, hinting perhaps at adipose tissue as a site of production. Elevated systemic IL-6 and TNF-alpha were limited to newly diagnosed cases suggesting activation of the inflammatory immune response system at early stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11849625     DOI: 10.1016/s0009-9120(01)00275-2

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  35 in total

1.  Altered Toll-like receptor signaling pathways in human type 1 diabetes.

Authors:  Adam J Meyers; Roopali R Shah; Peter A Gottlieb; Danny Zipris
Journal:  J Mol Med (Berl)       Date:  2010-08-20       Impact factor: 4.599

Review 2.  The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.

Authors:  Antonio Citro; Elisa Cantarelli; Lorenzo Piemonti
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

3.  C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia.

Authors:  Jaime Haidet; Vincenza Cifarelli; Massimo Trucco; Patrizia Luppi
Journal:  Inflamm Res       Date:  2011-09-27       Impact factor: 4.575

4.  Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.

Authors:  M Andrade Lima Gabbay; M N Sato; A J S Duarte; S A Dib
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

5.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

6.  Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis.

Authors:  Shao-gang Ma; Yue Jin; Wei Xu; Wen Hu; Feng Bai; Xiao-juan Wu
Journal:  Endocrine       Date:  2012-03-23       Impact factor: 3.633

7.  α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.

Authors:  Peter A Gottlieb; Aimon K Alkanani; Aaron W Michels; Eli C Lewis; Leland Shapiro; Charles A Dinarello; Danny Zipris
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

8.  Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus.

Authors:  Bradley J Van Sickle; Jill Simmons; Randon Hall; Miranda Raines; Kate Ness; Anna Spagnoli
Journal:  Cytokine       Date:  2009-09-20       Impact factor: 3.861

9.  Increased Expression of Monocyte CD11b (Mac-1) in Overweight Recent-Onset Type 1 Diabetic Children.

Authors:  Vincenza Cifarelli; Ingrid M Libman; Angela Deluca; Dorothy Becker; Massimo Trucco; Patrizia Luppi
Journal:  Rev Diabet Stud       Date:  2007-08-10

10.  Redox status and immune function in type I diabetes families.

Authors:  E Matteucci; G Malvaldi; F Fagnani; I Evangelista; O Giampietro
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.